Knight solid tumors and hematologic malignancies translational retreat   agenda-final
Upcoming SlideShare
Loading in...5
×
 

Knight solid tumors and hematologic malignancies translational retreat agenda-final

on

  • 293 views

 

Statistics

Views

Total Views
293
Views on SlideShare
293
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Knight solid tumors and hematologic malignancies translational retreat   agenda-final Knight solid tumors and hematologic malignancies translational retreat agenda-final Document Transcript

  • Solid Tumors and Hematologic Malignancies Translational Retreat June 21, 2011 Time: 12 – 5:30 PM - Location: CHH 3rd Floor Room 1 A & B Agenda Session 1 – Panel Discussion – Lunch Provided 12:00 – 1:15 “Translational research challenges and opportunities” Presentations (15 min each) and Panel discussion (30 min) William Stratford May, Jr. Visiting Professor; “Building translational teams” Joe Gray “Multidisciplinary teams in breast cancer” Panelists: Charles Lopez, Alan Sandler and Charles Keller Session 2 “Discovery, emerging technology and translation to clinical trials” 1:15 – 1:45 PM Jeffrey Tyner, PhD and Stephen Spurgeon, MD “New targets for hematologic and solid malignancies emerging from functional screens”. Molecular target development and therapeutics focus group. (20 min talk 10 min discussion) 1:45 – 2:15 PM Chris Ryan, MD “Innovations in tumor imaging for clinical trials and preclinical research”. Biopredictors and imaging focus group. (20 min for talks 10 min discussion) 2:15 - 2:30 PM – Break 2:30 – 3:15 PM Joe Gray, PhD “Modeling mechanisms of response to RTK targeted therapies in breast cancer”. (30 min talk and 10 min discussion) 3:15 – 3:45 PM Ariel Lopez-Chavez, MD, MS “Personalizing the diagnosis and treatment of lung cancer” (20 min talks and 10 min discussion) 4:00 – 5:00 PM Keynote Speaker: Dr. William Stratford May, Jr. Henry E. Innes Professor of Cancer Research, Department of Medicine, UF Shands Cancer Center Cancer and Genetics Research, Gainesville, FL. Title: “TNK1/KOS1: A Protein Tyrosine Kinase with a Tumor Suppressor Function”Send suggestions, comments or questions to knight@ohsu.edu.